Who is sponsoring NCT02237755?

NCT02237755 is sponsored by University of Athens.

What condition does NCT02237755 study?

NCT02237755 studies Female Infertility.

What drugs are being tested in NCT02237755?

Interventions: Clomiphene citrate, Gonadotropins.

What is the status of NCT02237755?

NCT02237755 is currently UNKNOWN.

Last reviewed 2014-09-09 · How we verify

Prospective Randomized Trial on the Effect of Clomiphene Citrate Administration in Women With Poor Ovarian Reserve Undergoing Controlled Ovarian Stimulation for IVF. Impact on Stimulation Characteristics and Pregnancy Outcome.

NCT02237755 Phase 2/Phase 3 UNKNOWN

Coadministration of various drugs used for ovarian stimulation can increase the efficiency of IVF especially in poor responders. The investigators hypothesize that ovarian response of those patients could improve by using combination of clomiphene citrate with gonadotropins in infertile women with poor response to gonadotrophin administration only.

Details

Lead sponsor	University of Athens
Phase	Phase 2/Phase 3
Status	UNKNOWN
Enrolment	50
Start date	2014-10
Completion	2015-12

Conditions

Female Infertility

Interventions

Clomiphene citrate
Gonadotropins

Primary outcomes

Clinical pregnancy — 14 days after embryo transfer
At the completion of the ovarian stimulation patients that will proceed to transfer and have a positive pregnancy test will have sonographic evaluation for confirmation of clinical pregnancy.